Table 3.
Association of Log(Skin Intrinsic Fluorescence) with Varying Glycemic Exposure Intervals
β (R2) at glycemic exposure interval | |||||
---|---|---|---|---|---|
EDIC | |||||
Last 5 years | Last 10 years | All years | EDIC+DCCT | EDIC+DCCT+baselinea | |
Mean HbA1c (%) | 0.028 (0.023) | 0.032 (0.027) | 0.037 (0.033) | 0.043 (0.038) | 0.048 (0.045) |
Age (years) | 0.011 (0.137) | 0.011 (0.137) | 0.011 (0.136) | 0.011 (0.146) | 0.012 (0.147) |
Any eGFR <60 mL/min/m2 to date (yes vs. no) | 0.140 (0.030) | 0.133 (0.027) | 0.122 (0.022) | 0.113 (0.019) | 0.106 (0.016) |
Smoking (current, former, never)b | 0.070 (0.058) | 0.069 (0.056) | 0.067 (0.053) | 0.067 (0.053) | 0.066 (0.052) |
Skin tone (arbitrary units) | 0.0008 (0.034) | 0.0008 (0.034) | 0.0008 (0.034) | 0.0008 (0.036) | 0.0008 (0.034) |
Clinic latitude >37o (south vs. north) | 0.055 (0.014) | 0.057 (0.015) | 0.056 (0.015) | 0.058 (0.015) | 0.057 (0.015) |
Total R2 (all variables) | 0.308 | 0.314 | 0.320 | 0.325 | 0.331 |
Data are β coefficients and squared semipartial R2 correlations from five separate linear regression models regressing log(skin intrinsic fluorescence) on various glycemic exposure intervals. Each model was simultaneously adjusted for age, any estimated glomerular filtration rate (eGFR) <60 mL/min/m2, smoking status, skin tone, and clinic latitude.
Total mean hemoglobin A1c (HbA1c) is calculated by summing (Diabetes Control and Complications Trial [DCCT]/Epidemiology of Diabetes Intervention and Complications [EDIC] eligibility HbA1c×duration of diabetes at study baseline), (DCCT mean HbA1c×years of follow-up on DCCT), and (EDIC mean HbA1c×years of follow-up in EDIC) and dividing by total duration of diabetes.
Current smoker defined as currently smoking or smoking within the last year; ever smoker defined as smoking more than a year ago.